feed,title,long_url,short_url
r/science:15+,[Epidemiology] The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC,https://redd.it/10lcgah,
